EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier

Ruben J. Boado

RSC Pharmaceutics · 2025 · 2 (6) · 1349-1375

DOI: 10.1039/d5pm00204d ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Ruben J. Boado. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The brain microvasculature represents the blood–brain barrier (BBB) in vivo and it is permeable only to small lipophilic molecules.

Zitieren

APA

Boado, R. J. (2025). Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier. RSC Pharmaceutics, 2(6), 1349-1375. https://doi.org/10.1039/d5pm00204d

Vancouver

Boado RJ. Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier. RSC Pharmaceutics. 2025;2(6):1349-1375. doi:10.1039/d5pm00204d

BibTeX
@article{Boado2025,
  author = {Boado, Ruben J.},
  title = {Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier},
  journal = {RSC Pharmaceutics},
  year = {2025},
  volume = {2},
  number = {6},
  pages = {1349--1375},
  doi = {10.1039/d5pm00204d}
}
Kostenlos starten →